Stimuli is a French revenue-stage medtech company focused on neuromodulation solutions for urology. Its flagship product, Tensi+, is a CE-marked, non-invasive neurostimulation device for overactive bladder, providing an effective drug-free alternative for patients. The device is already reimbursed by the French healthcare system, creating a favorable commercial framework for adoption and scaling. The company is initially targeting the urology market, with opportunities to expand into broader pelvic health indications.